EpCAM, a Potential Therapeutic Target for Esophageal Squamous Cell Carcinoma

被引:0
|
作者
Tatsuo Matsuda
Hiroya Takeuchi
Sachiko Matsuda
Kunihiko Hiraiwa
Taku Miyasho
Minoru Okamoto
Kazufumi Kawasako
Rieko Nakamura
Tsunehiro Takahashi
Norihito Wada
Hirofumi Kawakubo
Yoshiro Saikawa
Tai Omori
Yuko Kitagawa
机构
[1] Keio University School of Medicine,Department of Surgery
[2] Rakuno Gakuen University,Department of Veterinary Biochemistry, School of Veterinary Medicine
[3] Rakuno Gakuen University,Department of Veterinary Pathology, School of Veterinary Medicine
来源
关键词
Esophageal Squamous Cell Carcinoma; Esophageal Squamous Cell Carcinoma Cell; Esophageal Squamous Cell Carcinoma Patient; TE10 Cell; Esophageal Squamous Cell Carcinoma Cell Line;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:356 / 364
页数:8
相关论文
共 50 条
  • [21] Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma
    Shao, Ying
    Li, Peng
    Zhu, Sheng-tao
    Yue, Ji-ping
    Ji, Xiao-jun
    He, Zhen
    Ma, Dan
    Wang, Li
    Wang, Yong-jun
    Zong, Ye
    Wu, Yong-dong
    Zhang, Shu-tian
    PLOS ONE, 2015, 10 (11):
  • [23] Interleukin-6 as a potential molecular target in esophageal squamous cell carcinoma
    Zhao, Zhi-Fei
    Li, Jian-Xiong
    Ye, Rui
    Wu, Xuan
    Gao, Ling-Ling
    Niu, Bao-Long
    ONCOLOGY LETTERS, 2016, 11 (02) : 925 - 932
  • [24] Potential Therapeutic Significance of HER-Family in Esophageal Squamous Cell Carcinoma
    Kono, Koji
    Mimura, Kousaku
    Fujii, Hideki
    Shabbir, Asim
    Yong, Wei-Peng
    So, Jimmy
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 18 (06) : 506 - 513
  • [25] Molecular pathology and potential therapeutic targets in esophageal basaloid squamous cell carcinoma
    Saito, Tsuyoshi
    Mitomi, Hiroyuki
    Yao, Takashi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (03): : 2267 - 2273
  • [26] Bmi1 Severs as a Potential Tumor-Initiating Cell Marker and Therapeutic Target in Esophageal Squamous Cell Carcinoma
    Wang, Xiaochen
    Li, Kang
    Cheng, Maosheng
    Wang, Ganping
    Han, Hui
    Chen, Fangfang
    Liao, Wenjing
    Chen, Zhi
    Chen, Jianwen
    Bao, Yong
    Peng, Liang
    Chen, Demeng
    STEM CELLS INTERNATIONAL, 2020, 2020
  • [27] Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma
    Chu, Jiahui
    Niu, Xiangjie
    Chang, Jiang
    Shao, Mingming
    Peng, Linna
    Xi, Yiyi
    Lin, Ai
    Wang, Chengcheng
    Cui, Qionghua
    Luo, Yingying
    Fan, Wenyi
    Chen, Yamei
    Sun, Yanxia
    Guo, Wenjia
    Tan, Wen
    Lin, Dongxin
    Wu, Chen
    THERANOSTICS, 2020, 10 (08): : 3488 - 3502
  • [28] PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma
    Xiao-bin Cui
    Shu-mao Zhang
    Yue-xun Xu
    Hong-wei Dang
    Chun-xia Liu
    Liang-hai Wang
    Lan Yang
    Jian-ming Hu
    Wei-hua Liang
    Jin-fang Jiang
    Na Li
    Yong Li
    Yun-zhao Chen
    Feng Li
    Journal of Translational Medicine, 14
  • [29] PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma
    Cui, Xiao-bin
    Zhang, Shu-mao
    Xu, Yue-xun
    Dang, Hong-wei
    Liu, Chun-xia
    Wang, Liang-hai
    Yang, Lan
    Hu, Jian-ming
    Liang, Wei-hua
    Jiang, Jin-fang
    Li, Na
    Li, Yong
    Chen, Yun-zhao
    Li, Feng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [30] Phosphotyrosine profiling identifies ephrin receptor A2 as a potential therapeutic target in esophageal squamous-cell carcinoma
    Syed, Nazia
    Barbhuiya, Mustafa A.
    Pinto, Sneha M.
    Nirujogi, Raja Sekhar
    Renuse, Santosh
    Datta, Keshava K.
    Khan, Aafaque Ahmad
    Srikumar, Kotteazeth
    Prasad, T. S. Keshava
    Kumar, M. Vijaya
    Kumar, Rekha Vijay
    Chatterjee, Aditi
    Pandey, Akhilesh
    Gowda, Harsha
    PROTEOMICS, 2015, 15 (2-3) : 374 - 382